RIO DE JANEIRO, BRAZIL - The lack of raw materials for the manufacture of covid-19 antidotes in Brazil is once again threatening the continuity of vaccination in the South American giant, where the rate of immunizations has plummeted by about 60% in two weeks.
The two covid vaccines that have been most widely used in the country are produced on Brazilian soil with raw materials from China, which are already becoming scarce in the country.
The Butantan Institute in São Paulo, which has delivered 60% of the antidotes for the vaccination campaign in the country, suspended as of this . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here